Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


13.08.2018

2 Antiviral Res
1 Drugs
1 J Gen Virol
1 J Infect
3 J Infect Dis
2 J Virol
1 JAMA
2 Lancet Respir Med
1 PLoS One
5 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antiviral Res

  1. BRODSKAIA AV, Timin AS, Gorshkov AN, Muslimov AR, et al
    Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Antiviral Res. 2018 Aug 6. pii: S0166-3542(17)30732.
    PubMed     Text format     Abstract available

  2. GARG R, Brownlie R, Latimer L, Gerdts V, et al
    A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
    Antiviral Res. 2018;158:78-87.
    PubMed     Text format     Abstract available


    Drugs

  3. FOX A, Quinn KM, Subbarao K
    Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.
    Drugs. 2018 Aug 7. pii: 10.1007/s40265-018-0958.
    PubMed     Text format     Abstract available


    J Gen Virol

  4. LAMBERTZ RLO, Pippel J, Gerhauser I, Kollmus H, et al
    Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice.
    J Gen Virol. 2018 Aug 6. doi: 10.1099/jgv.0.001128.
    PubMed     Text format     Abstract available


    J Infect

  5. GUO F, Luo T, Pu Z, Xiang D, et al
    Increasing the potential ability of human infections in H5N6 avian influenza A viruses.
    J Infect. 2018 Aug 2. pii: S0163-4453(18)30242.
    PubMed     Text format    


    J Infect Dis

  6. SCHULTZ-CHERRY S
    Beyond Disease Severity: The Impact of Obesity on Influenza A Virus Shedding.
    J Infect Dis. 2018 Aug 2. pii: 5051914. doi: 10.1093.
    PubMed     Text format    

  7. LOY H, Kuok DIT, Hui KPY, Choi MHL, et al
    Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A/H5N1-associated acute lung injury.
    J Infect Dis. 2018 Aug 2. pii: 5064213. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. MAIER HE, Lopez R, Sanchez N, Ng S, et al
    Obesity Increases the Duration of Influenza A Virus Shedding in Adults.
    J Infect Dis. 2018 Aug 2. pii: 5051913. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  9. DU W, Dai M, Li Z, Boons GJ, et al
    Substrate binding by the 2(nd) sialic acid-binding site of influenza A virus N1 neuraminidase contributes to enzymatic activity.
    J Virol. 2018 Aug 8. pii: JVI.01243-18. doi: 10.1128/JVI.01243.
    PubMed     Text format     Abstract available

  10. KIM YJ, Kim KH, Ko EJ, Kim MC, et al
    Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain Specific HA or Cross Protective M2e vaccination.
    J Virol. 2018 Aug 1. pii: JVI.00969-18. doi: 10.1128/JVI.00969.
    PubMed     Text format     Abstract available


    JAMA

  11. UYEKI TM, Fowler RA, Fischer WA 2nd
    Gaps in the Clinical Management of Influenza: A Century Since the 1918 Pandemic.
    JAMA. 2018 Jul 30. pii: 2695951. doi: 10.1001/jama.2018.8113.
    PubMed     Text format    


    Lancet Respir Med

  12. LAMOTH F, Calandra T
    Let's add invasive aspergillosis to the list of influenza complications.
    Lancet Respir Med. 2018 Jul 31. pii: S2213-2600(18)30332.
    PubMed     Text format    

  13. SCHAUWVLIEGHE AFAD, Rijnders BJA, Philips N, Verwijs R, et al
    Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
    Lancet Respir Med. 2018 Jul 31. pii: S2213-2600(18)30274.
    PubMed     Text format     Abstract available


    PLoS One

  14. MAZAGATOS C, Delgado-Sanz C, Oliva J, Gherasim A, et al
    Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    PLoS One. 2018;13:e0200934.
    PubMed     Text format     Abstract available


    Vaccine

  15. SHINJOH M, Sugaya N, Yamaguchi Y, Iibuchi N, et al
    Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
    Vaccine. 2018 Aug 6. pii: S0264-410X(18)31074.
    PubMed     Text format     Abstract available

  16. WU S, Pan Y, Zhang X, Zhang L, et al
    Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31097.
    PubMed     Text format     Abstract available

  17. YEUNG KHT, Tarrant M, Chan KCC, Tam WH, et al
    Increasing influenza vaccine uptake in children: A randomised controlled trial.
    Vaccine. 2018 Aug 2. pii: S0264-410X(18)31075.
    PubMed     Text format     Abstract available

  18. THOMPSON MG, Pierse N, Sue Huang Q, Prasad N, et al
    Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Vaccine. 2018 Aug 1. pii: S0264-410X(18)30997.
    PubMed     Text format     Abstract available

  19. ORTQVIST A, Brytting M, Leval A, Hergens MP, et al
    Impact of repeated influenza vaccinations in persons over 65years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31046.
    PubMed     Text format     Abstract available


    Virology

  20. SUTTIE A, Karlsson EA, Deng YM, Horm SV, et al
    Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.
    Virology. 2018;523:22-26.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: